Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Ранг среди акций #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Цена акции
$1.51
Последняя синхронизация: 2024-08-26
Рыночная капитализация
$1.12M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Agile Therapeutics, Inc. (AGRX)

Категория

Выручка компании Agile Therapeutics, Inc. (AGRX)
Выручка на Jun 2024 TTM: $21.57M
Согласно последним финансовым отчетам Agile Therapeutics, Inc., текущая выручка компании (TTM) составляет $21.57M. В 2022 году компания получила выручку $10.88M больше, чем выручке в 2021 году, которая составила $4.10M. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Agile Therapeutics, Inc. с 2012 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $21.57M 10.08%
2023 $19.59M 80.02%
2022 $10.88M 165.40%
2021 $4.10M 447.53%
2020 $749.00K 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
- -
DE
- -
DE
- -
JP
- -
CH
$6.61B 30,554.91%
IN